Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Douglas Griffin, M.D.

Concepts (1107)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with James Griffin's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that James Griffin has written about over time.
Colony-Stimulating Factors, 49 publications between 1983 and 1990, average publication date April 1988. Growth Substances, 31 publications between 1987 and 2002, average publication date May 1989. Hematopoietic Stem Cells, 65 publications between 1982 and 2005, average publication date June 1991. Leukemia, Myeloid, 37 publications between 1982 and 2020, average publication date March 1994. Interleukin-3, 35 publications between 1987 and 2005, average publication date June 1995. Leukemia, Myeloid, Acute, 74 publications between 1981 and 2022, average publication date September 1997. Leukemia, 21 publications between 1981 and 2016, average publication date January 1998. Proto-Oncogene Proteins, 54 publications between 1988 and 2018, average publication date December 1998. Cell Transformation, Neoplastic, 35 publications between 1980 and 2011, average publication date March 2000. Protein-Tyrosine Kinases, 62 publications between 1990 and 2014, average publication date August 2000. Fusion Proteins, bcr-abl, 60 publications between 1992 and 2014, average publication date May 2001. Leukemia, Myelogenous, Chronic, BCR-ABL Positive, 44 publications between 1988 and 2021, average publication date September 2002. Piperazines, 41 publications between 1992 and 2016, average publication date January 2005. Pyrimidines, 50 publications between 1999 and 2016, average publication date February 2006. Antineoplastic Agents, 51 publications between 1981 and 2022, average publication date March 2007. Drug Resistance, Neoplasm, 32 publications between 2001 and 2019, average publication date October 2008. Staurosporine, 24 publications between 2002 and 2020, average publication date March 2009. fms-Like Tyrosine Kinase 3, 38 publications between 2001 and 2021, average publication date February 2010. Protein Kinase Inhibitors, 39 publications between 1992 and 2020, average publication date October 2011.

To see the data from this visualization as text, click here.
Griffin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (1107)
Explore
_
Co-Authors (142)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.